New CTO Set to Revolutionize Scripta Insights in Healthcare Technology Sector

Scripta Insights has announced the appointment of David Kershaw as their new Chief Technology Officer (CTO). This news comes after a year of remarkable growth for the company, which includes the launch of their enhanced member app and a partnership with Cost Plus Drugs, owned by Mark Cuban.

In his new role, Kershaw will be responsible for driving Scripta’s technological vision and strategy. He will also lead innovation initiatives, oversee the engineering and IT teams, and work towards providing groundbreaking solutions like Scripta’s Med Mapper and member app, an Rx comparison-shopping tool.

Eric Levin, CEO of Scripta Insights, expressed his excitement about Kershaw joining the team. He highlighted Kershaw’s successful track record and his passion for improving people’s quality of life through technology. Levin believes that Kershaw’s expertise will be invaluable as Scripta continues to grow and innovate in the pharmacy benefits landscape.

Kershaw brings over 20 years of experience in leading engineering teams across various industries, including healthcare and biotech. He has previously held leadership positions at Tactiq, DataKitchen, and the Broad Institute of MIT and Harvard. Kershaw holds a Master’s degree in Industrial Policy from Harvard University.

Scripta Insights is a venture-backed digital health company that specializes in developing pharmacy navigation solutions for self-insured employers, health plans, and their members. The company is dedicated to transforming the pharmacy benefits landscape and helping clients and their members save on prescription costs through innovative technology solutions.